A variety of benign and malignant non-squamous cell neoplasms may affe
ct the larynx. Most of these uncommon laryngeal neoplasms are located
beneath an intact mucosa, making diagnosis difficult with endoscopy al
one, and sampling errors may occur if only traditional superficial bio
psies are performed. In some laryngeal neoplasms, radiologic evaluatio
n allows the correct diagnosis. Hemangiomas have very high signal inte
nsity at m-weighted magnetic resonance (MR) imaging and strong enhance
ment at both computed tomography (CT) and MR imaging after administrat
ion of contrast material. Phleboliths, which are pathognomonic for hem
angiomas, are easily identified at CT. Chondrogenic tumors typically m
anifest with coarse or stippled calcifications at CT. Because of their
high water content, chondrogenic tumors have very high signal intensi
ty on T2-weighted MR images, whereas only moderate enhancement is obse
rved after administration of contrast material. Lipomas typically mani
fest at both CT and MR imaging as homogeneous nonenhancing lesions. Th
ey are isoattenuating to subcutaneous fat at CT and isointense relativ
e to subcutaneous fat with all MR pulse sequences. Metastases from ren
al adenocarcinoma typically demonstrate strong contrast enhancement an
d now voids at MR imaging, and metastases from melanotic melanoma usua
lly have high signal intensity on T1-weighted MR images and low signal
intensity on T2-weighted images owing to the paramagnetic properties
of melanin. Although radiologic findings are nonspecific in most other
non-squamous cell neoplasms of the larynx (eg, Kaposi sarcoma, hemato
poietic tumors, tumors of the minor salivary glands, metastases from a
melanotic melanoma), cross-sectional imaging can play an important rol
e in the diagnostic work-up of these unusual tumors by delineating the
extent of submucosal tumor spread and directing the endoscopist to th
e appropriate site for the deep, transmucosal biopsies needed to estab
lish the diagnosis. In addition, CT and MR imaging are crucial for pos
ttherapeutic monitoring and early detection of local recurrence.